V003-4850 Screening compound: N-[4-(4-chlorophenyl)-1-(3,4-dimethoxyphenyl)-1H-imidazol-2-yl]-2-{N-[2-(morpholin-4-yl)ethyl]-1-(thiophen-2-yl)formamido}acetamide

V003-4850 Screening compound: N-[4-(4-chlorophenyl)-1-(3,4-dimethoxyphenyl)-1H-imidazol-2-yl]-2-{N-[2-(morpholin-4-yl)ethyl]-1-(thiophen-2-yl)formamido}acetamide
V003-4850 Screening compound: N-[4-(4-chlorophenyl)-1-(3,4-dimethoxyphenyl)-1H-imidazol-2-yl]-2-{N-[2-(morpholin-4-yl)ethyl]-1-(thiophen-2-yl)formamido}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V003-4850
N-[4-(4-chlorophenyl)-1-(3,4-dimethoxyphenyl)-1H-imidazol-2-yl]-2-{N-[2-(morpholin-4-yl)ethyl]-1-(thiophen-2-yl)formamido}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V003-4850

Molecular Formula

C30H32ClN5O5S (C30 H32 ClN5 O5 S)

Compound Name

N-[4-(4-chlorophenyl)-1-(3,4-dimethoxyphenyl)-1H-imidazol-2-yl]-2-{N-[2-(morpholin-4-yl)ethyl]-1-(thiophen-2-yl)formamido}acetamide

IUPAC name

N-[4-(4-chlorophenyl)-1-(34-dimethoxyphenyl)-1H-imidazol-2-yl]-2-{N-[2-(morpholin-4-yl)ethyl]-1-(thiophen-2-yl)formamido}acetamide

SMILES

COc(ccc(-n1c(NC(CN(CCN2CCOCC2)C(c2cccs2)=O)=O)nc(-c(cc2)ccc2Cl)c1)c1)c1OC

InChI

InChI=1S/C30H32ClN5O5S/c1-39-25-10-9-23(18-26(25)40-2)36-19-24(21-5-7-22(31)8-6-21)32-30(36)33-28(37)20-35(29(38)27-4-3-17-42-27)12-11-34-13-15-41-16-14-34/h3-10,17-19H,11-16,20H2,1-2H3,(H,32,33,37)

InChI Key

JHPGMMJCVLZNHV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19825264

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

610.13

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

4.480

Distribution Coefficient, logD

4.470

Water Solubility, LogSw

-4.56

Polar Surface Area

80.542

Acid Dissociation Constant (pKa)

13.38

Base Dissociation Constant (pKb)

5.75

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.00

V003-4850 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

GPCR Targeted Library (31838 compounds)

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V003-4850 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V003-4850?
Check Price and Availability of V003-4850, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V003-4850 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V003-4850
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V003-4850
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V003-4850 available by request